Growth or death? Control of cell destiny by mTOR and autophagy pathways

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• The mammalian target of rapamycin (mTOR) is a key regulator of cell growth, proliferation, and metabolism, existing as mTORC1 and mTORC2 complexes.
• mTORC1 is nutrient-sensitive and rapamycin-inhibited, playing roles in protein synthesis, gene transcription, and tumor metabolism.
• Autophagy, a cellular recycling process, is crucial for nutrient starvation response and is linked to diseases like cancer and aging.

Purpose of the Study:

• To review the intricate signaling pathways of mTOR and autophagy.
• To elucidate the regulatory mechanisms governing the interplay between mTOR and autophagy.
• To explore the therapeutic potential of targeting the mTOR-autophagy axis.

Main Methods:

• Literature review of scientific publications on mTOR and autophagy signaling.
• Analysis of the regulatory roles of mTOR in different stages of autophagy.
• Examination of evidence linking mTOR pathway activation and autophagy dysregulation in diseases.

Main Results:

• The mTOR signaling pathway is frequently hyperactivated in tumors.
• mTOR directly inhibits autophagy induction, from autophagosome formation to lysosome degradation.
• Dysregulation of autophagy is implicated in cancer development and aging processes.

Conclusions:

• The mTOR pathway's central role in cell growth and its inhibition of autophagy present a therapeutic target.
• Modulating autophagy via mTOR inhibitors could offer a novel strategy for treating mTOR-driven diseases.
• Understanding mTOR-autophagy regulation is critical for developing new therapeutic interventions.